Validation of Neutrophil-to-Lymphocyte Ratio Cut-off Value Associated with High In-Hospital Mortality in COVID-19 Patients

References

• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. doi:10.1016/S0140-6736(20)30566-3
   PubMed Web of Science ®Google Scholar
• Zeberg H, Pääbo S. The major genetic risk factor for severe COVID-19 is inherited from Neanderthals. Nature. 2020;587(7835):610–612. doi:10.1038/s41586-020-2818-3
   PubMed Web of Science ®Google Scholar
• Zhang Q, Bastard P, Liu Z, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370(6515):eabd4570. doi:10.1126/science.abd4570
   PubMed Web of Science ®Google Scholar
• Bennett S, Tafuro J, Mayer J, et al. Clinical features and outcomes of adults with COVID-19: a systematic review and pooled analysis of the literature. Int J Clin Pract. 2020;75:e13725. doi:10.1111/ijcp.13725.
   PubMed Web of Science ®Google Scholar
• Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934. doi:10.1001/jamainternmed.2020.0994
   PubMed Web of Science ®Google Scholar
• Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97:829–838. doi:10.1016/j.kint.2020.03.005
   PubMed Web of Science ®Google Scholar
• Wynants L, Calster BV, Bonten MMJ, et al. Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal. bmj. 2020;369:m1328. doi:10.1136/bmj.m1328
   Web of Science ®Google Scholar
• Knight SR, Ho A, Pius R. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ. 2020;370:m3339. doi:10.1136/bmj.m3339
   PubMed Web of Science ®Google Scholar
• Yildiz H, Yombi JC, Castanares-Zapatero D. Validation of a risk score to predict patients at risk of critical illness with COVID-19. Infect Dis (Lond). 2021;53(1):78–80. doi:10.1080/23744235.2020.1823469
   PubMed Web of Science ®Google Scholar
• Li X, Liu C, Mao Z, et al. Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis. Crit Care. 2020;24(1):647. doi:10.1186/s13054-020-03374-8
   PubMed Web of Science ®Google Scholar
• Liu L, Zheng Y, Cai L, et al. Neutrophil-to-lymphocyte ratio, a critical predictor for assessment of disease severity in patients with COVID-19. Int J Lab Hematol. 2021;43(2):329–335. doi:10.1111/ijlh.13374
   PubMed Web of Science ®Google Scholar
• Liang W, Liang H, Ou L, et al. Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19. JAMA Intern Med. 2020;180(8):1081. doi:10.1001/jamainternmed.2020.2033
   PubMed Web of Science ®Google Scholar
• Liu Y, Du X, Chen J, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect. 2020;81:e6–e12. doi:10.1016/j.jinf.2020.04.002
   Web of Science ®Google Scholar
• Liu J, Liu Y, Xiang P, et al. Neutrophil-to-lymphocyte count predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med. 2020;18:206. doi:10.1186/s12967-020-02374-0
   PubMed Web of Science ®Google Scholar
• Niessen R, Bihin B, Gourdin M, Yombi JC, Cornu O, Forget P. Prediction of postoperative mortality in elderly patient with hip fractures: a single-centre, retrospective cohort study. BMC Anesthesiol. 2018;18:183. doi:10.1186/s12871-018-0646-x
   PubMed Web of Science ®Google Scholar
• Faria SS, Fernandes PJ, Silva MJ. The neutrophil-to-lymphocyte ratio: a narrative review. Ecancermedicalscience. 2016;10:702.
   PubMed Web of Science ®Google Scholar
• Azab B, Zaher M, Weiserbs KF. Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST elevation myocardial infarction. Am J Cardiol. 2010;106:470–476. doi:10.1016/j.amjcard.2010.03.062
   PubMed Web of Science ®Google Scholar
• Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88:218–230. doi:10.1016/j.critrevonc.2013.03.010
   PubMed Web of Science ®Google Scholar
• Lian J, Jin C, Hao S, et al. High neutrophil-to-lymphocyte ratio associated with progression to critical illness in older patients with COVID-19: a multicenter retrospective study. Aging (Albany NY). 2020;30(12):13849–13859. doi:10.18632/aging.103582
   Google Scholar
• Zhang JJ, Cao YY, Tan G, et al. Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients. Allergy. 2021;76(2):533–550. doi:10.1111/all.14496
   PubMed Web of Science ®Google Scholar
• Fu J, Kong J, Wang W, et al. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: a retrospective study in Suzhou China. Thromb Res. 2020;192:3–8. doi:10.1016/j.thromres.2020.05.006
   PubMed Web of Science ®Google Scholar
• Liao D, Zhou F, Luo L, et al. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study. Lancet Haematol. 2020;7(9):e671–e678. doi:10.1016/S2352-3026(20)30217-9
   PubMed Web of Science ®Google Scholar
• Nalbant A, Kaya T, Varim C, Yaylaci S, Tamer A, Cinemre H. Can the neutrophil/lymphocyte ratio (NLR) have a role in the diagnosis of coronavirus 2019 disease (COVID-19)? Rev Assoc Med Bras (1992). 2020;66(6):746–751. doi:10.1590/1806-9282.66.6.746
   PubMed Web of Science ®Google Scholar
• Ma A, Cheng J, Yang J, Dong M, Liao X, Kang Y. Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients. Crit Care. 2020;24(1):288. doi:10.1186/s13054-020-03007-0
   PubMed Web of Science ®Google Scholar
• Li Y, Hou H, Diao J, Wang Y, Yang H. Neutrophil-to-lymphocyte ratio is independently associated with COVID-19 severity: an updated meta-analysis based on adjusted effect estimates. Int J Lab Hematol. Epub 2021 Jan 27. doi:10.1111/ijlh.13475
   Web of Science ®Google Scholar
• Hariyanto TI, Japar KV, Kwenandar F, et al. Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: a systematic review and meta-analysis. Am J Emerg Med. 2021;41:110–119. doi:10.1016/j.ajem.2020.12.076
   PubMed Web of Science ®Google Scholar
• Zahorec R. Ratio of neutrophil to lymphocyte counts—rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102:5–14.
   PubMedGoogle Scholar
• Heffernan DS, Monaghan SF, Thakkar RK, Machan JT, Cioffi WG, Ayala A. Failure to normalize lymphopenia following trauma is associated with increased mortality, independent of the leukocytosis pattern. Crit Care. 2012;16:R12. doi:10.1186/cc11157
   PubMed Web of Science ®Google Scholar
• Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033–1034. doi:10.1016/S0140-6736(20)30628-0
   PubMed Web of Science ®Google Scholar
• Gidari A, Vittorio De Socia G, Sabbatini S, et al. Predictive value of National Early Warning Score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection. Infect Dis (Lond). 2020;52(10):698–704. doi:10.1080/23744235.2020.1784457
   PubMed Web of Science ®Google Scholar
• Yildiz H, Castanares-Zapatero D, Hannesse C, Vandermeersch D, Pothen L, Yombi JC. Prospective validation and comparison of COVID-GRAM, NEWS2, 4C mortality score, CURB-65 for the prediction of critical illness in COVID-19 patients. Infect Dis (Lond). Epub 2021 Mar 10. doi:10.1080/23744235.2021.1896777
   Web of Science ®Google Scholar
• Hou W, Zhao Z, Chen A, Li H, Duong TQ. Machining learning predicts the need for escalated care and mortality in COVID-19 patients from clinical variables. Int J Med Sci. 2021;18(8):1739–1745. doi:10.7150/ijms.51235
   PubMed Web of Science ®Google Scholar
• Zhu JS, Ge P, Jiang C, et al. Deep-learning artificial intelligence analysis of clinical variables predicts mortality in COVID-19 patients. J Am Coll Emerg Physicians Open. 2020;1(6):1364–1373. doi:10.1002/emp2.12205
   PubMedGoogle Scholar
• Lu JQ, Musheyev B, Peng Q, Duong TQ. Neural network analysis of clinical variables predicts escalated care in COVID-19 patients: a retrospective study. PeerJ. 2021;9:e11205. doi:10.7717/peerj.11205
   PubMed Web of Science ®Google Scholar
• Jiang X, Coffee M, Bari A, et al. Towards an artificial intelligence framework for data-driven prediction of coronavirus clinical severity. Computers, Materials and Continua. 2020;63(1). doi:10.32604/cmc.2020.010691
   Web of Science ®Google Scholar
• Li X, Ge P, Zhu J, et al. Deep learning prediction of likelihood of ICU admission and mortality in COVID-19 patients using clinical variables. PeerJ. 2020;8:e10337. doi:10.7717/peerj.10337
   PubMed Web of Science ®Google Scholar
• Abrams EM, Szefler SJ. COVID-19 and the impact of social determinants of health. Lancet Respir Med. 2020;8(7):659–661. doi:10.1016/S2213-2600(20)30234-4
   PubMed Web of Science ®Google Scholar
• Hariyanto TI, Kurniawan A. Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection. Obes Med. 2020;19:100290. doi:10.1016/j.obmed.2020.100290
   Google Scholar
• Hariyanto TI, Lugito NPH, Yanto TA, Siregar JI, Kurniawan A. Insulin therapy and outcome from coronavirus disease 2019 (COVID-19): a Systematic Review, Meta-Analysis, and Meta-Regression. Endocr Metab Immune Disord Drug Targets. Epub 2021 Jul 09. doi:10.2174/1871530321666210709164925
   Web of Science ®Google Scholar
• Hariyanto TI, Kurniawan A. Dipeptidyl peptidase 4 (DPP4) inhibitor and outcome from coronavirus disease 2019 (COVID-19) in diabetic patients: a systematic review, meta-analysis, and meta-regression. J Diabetes Metab Disord. 2021;20(1):1–8. doi:10.1007/s40200-021-00777-4
   PubMed Web of Science ®Google Scholar
• Kosiborod MN, Esterline R, Furtado RHM, et al. Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, Phase 3 trial. Lancet Diabetes Endocrinol. 2021;9:586–594. doi:10.1016/S2213-8587(21)00180-7
   PubMed Web of Science ®Google Scholar